Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade. (June 2020)

• Record Type: Journal Article
• Authors: Tomoaia, Raluca; Beyer, Ruxandra Ș.; Pop, Dana; Minciună, Ioan A.; Dădârlat-Pop, Alexandra
• Is Part Of: European journal of cancer. Volume 132(2020)
• Page Start: 224
• Page End: 227
• Publication Date: 2020-06
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/j.ejca.2020.03.003
• Languages: English
• ISSNs: 0959-8049

Abstract

Highlights: Myocarditis is a rare side-effect of immunotherapy; it can be associated with other forms of immune-related adverse events. Cardiotoxicity should be considered as differential diagnosis of heart failure in patients on immunotherapy. Diagnosis of immune-related adverse events are diagnosed if the same T cells markers in damaged organs and in the tumour.